NATION PANDEMIC Serum Institute of India COVID-19 Vaccine advances to trial for phase-III on 1500 Indian patients Sep 15, 2020
PANDEMIC WORLD UK Pharmaceutical company AstraZeneca stops Coronavirus vaccine trial after unforeseen illness in voluntary Sep 9, 2020
Serum Institute CEO, Adar Poonawalla remains optimistic on development of Oxford COVID-19 Vaccine Sep 8, 2020